Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on 4D Medical.
RELATED STOCKHEAD STORIES
News
10 at 10: Investors have been brave enough to back these stocks this morning
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Reporting Season Round Up: Leading the charge was Playside – the ASX’s local games developer
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
News
ASX Small Cap Lunch Wrap: Who’s obsessed with their precious metals today?
Health & Biotech
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
ASX health stocks: 4D Medical leads after ramping up its game in the US
News
Quarterlies Top 5: Cokal and MSL were today’s top performers
News
Here’s how we should pick stocks after the ‘tick-like’ COVID recovery, according to two money managers
News
Last Orders: ASX falls despite strong jobs data
News
Market highlights and 5 ASX small caps to watch on Thursday
IPO Watch
Blast From the Past: How are last year’s ASX IPOs holding up in 2021?
Health & Biotech
Dr Boreham’s Crucible: Is 4D Medical breathing easier with Pro Medicus manning the bellows?
News
Last Orders: Tech and materials sell off reaches the ASX
Health & Biotech